SavedAdd your journal

Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2020 / Cilt: 30 - Sayı: 3

The Assessment of the Relationship Between ABO Blood Groups and Covid-19 Infection

Sude Hatun AKTIMUR
Ahmet SEN
Bahadır YAZICIOĞLU
Ahmet Kursad GUNES
Serhat GENC
Pages
121–125
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Compared to the blood groups of the healthy control group, COVID-19 patients had higher A blood group than the healthy group (62& vs.46.6%; p< 0.001) and lesser of the O blood group (19.6% vs. 34.7%; p< 0.001).Blood group A can be used as a predictive biomarker for COVID-19 disease.In addition, we concluded that the group A had a higher risk for COVID-19 disease and severity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The new coronavirus disease-2019 (COVID-19) is rapidly spreading around the world and has been declared an outbreak by WHO.
📊
Key Findings & Data:However, the effect of blood groups on COVID-19 infection and the severity of the disease is unclear.
💡
Conclusion & Impact:Compared to the blood groups of the healthy control group, COVID-19 patients had higher A blood group than the healthy group (62& vs.46.6%; p< 0.001) and lesser of the O blood group (19.6% vs. 34.7%; p< 0.001).Blood group A can be used as a predictive biomarker for COVID-19 disease.In addition, we concluded that the group A had a higher risk for COVID-19 disease and severity.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

The new coronavirus disease-2019 (COVID-19) is rapidly spreading around the world and has been declared an outbreak by WHO. However, the effect of blood groups on COVID-19 infection and the severity of the disease is unclear. The aim of this study is to determine the relationship between ABO blood group and susceptibility to COVID-19 infection and whether the blood group will be a biomarker for COVID-19 infection. Patients diagnosed with SARS-CoV-2 between March and May 2020 were included in this study. In order to compare the blood groups of the patients with the healthy group, patients who had previously performed ABO blood group analysis in the blood bank between February and May 2020 were included as the control group. Demographic data, clinical data, underlying comorbidities, laboratory findings and clinical results (hospitalization, need for intensive care, mortality) were obtained from the electronic medical records. A total of 179 patients with confirmed COVID-19 and 5200 healthy control patients were included in the study. Patients with COVID-19 showed a distribution of 62.01% in group A,9.50% in group B, 8.94% in group AB and 19.55% in group O. In group A, length of stay in Intensive Care Unit was longer (10.42±11.61 days; p= 0.013). Compared to the blood groups of the healthy control group, COVID-19 patients had higher A blood group than the healthy group (62& vs.46.6%; p< 0.001) and lesser of the O blood group (19.6% vs. 34.7%; p< 0.001).Blood group A can be used as a predictive biomarker for COVID-19 disease.In addition, we concluded that the group A had a higher risk for COVID-19 disease and severity.

🔖

Cite This Article

AKTIMUR, S. H., SEN, A., YAZICIOĞLU, B., GUNES, A. K., GENC, S. (2020). The Assessment of the Relationship Between ABO Blood Groups and Covid-19 Infection. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 30 - Sayı: 3, 121–125. https://ajindex.com/articles/323128

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Chen L, Liu W, Zhang Q, et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect 9: 313-319, 2020
  2. Coronavirus disease (COVID-19) pandemic. https:// www.who.int/docs/default-source/coronaviruse/ situation-reports/20200311-sitrep-51-covid-19. pdf?sfvrsn=1ba62e57_10 (Access Date 01/06/2020)
  3. Coronavirus disease (COVID-19) Situation Report – 134 2020. https://www.who.int/docs/default-source/coronaviruse/ situation-reports/20200602-covid-19-sitrep-134. pdf?sfvrsn=cc95e5d5_2 (Access Date 02/06/2020)
  4. Zhao J, Yang Y, Huang H, et al. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. medRxiv. 2020: 2020.03.11.20031096
  5. Li J, Wang X, Chen J, et al. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br J Haematol 190: 24-27, 2020
  6. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395: 507-513, 2020
  7. Reid ME, Bird GW. Associations between human red cell blood group antigens and disease. Transfus Med Rev. 1990;4: 47-55, 1996
  8. Pinkston JA, Cole P. ABO blood groups and salivary gland tumors (Alabama, United States). Cancer Causes Control 7: 572-574, 1996
  9. Tyagi SP, Tiagi GK, Pradhan S. ABO blood groups in relation to cancer cervix. Indian J Med Sci 21: 611-615, 1967
  10. Batool Z, Durrani SH, Tariq S. Association of ABO and Rh blood group types to hepatitis B, hepatitis C, HIV and syphilis infection, a five year’ experience in healthy blood donors in a tertiary care hospital. J Ayub Med Coll Abbottabad 29: 90-92, 2017
  11. Lindesmith L, Moe C, Marionneau S, et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med 9: 548-553, 2003
  12. Cheng Y, Cheng G, Chui CH, et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA 293: 1450-1451, 2005
  13. Borén T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262: 1892-1895, 1993
  14. Guillon P, Clément M, Sébille V, et al. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology 18: 1085-1093, 2008
  15. Zietz M, Tatonetti NP. Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv. 2020